The manufacturing of medicinal products is for us not only a matter of implementing a certain technological process, but a human mission based on high standards of quality, safety and efficacy of medications
Sopharma AD hereby informs thaton 14 December 2017 the Company bought 3 000 own shares representing 0.0022% of the share capital of the Company, at a total value of 12 855.00 BGN on the Bulgarian Stock Exchange, the average price per share was 4.285 BGN.
The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.
Sopharma AD hereby informs thaton 13 December 2017 the Company bought 6 251 own shares representing 0.0046% of the share capital of the Company, at a total value of 26 753.18 BGN on the Bulgarian Stock Exchange, the average price per share was 4.28 BGN.
The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.
